← Leaderboards
Li-Tzy T Wu
Research Triangle Institute
$8,276,349
Attributed
$8,723,943
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,699,371 · 14
By mechanism
UG1$9,790,116 · 3
R01$5,401,237 · 4
R33$1,097,958 · 1
R21$1,045,777 · 3
R03$339,193 · 2
P20$25,090 · 1
Top collaborators
- Rowena J Dolor12 shared
- William Scott John1 shared
Most similar at Research Triangle Institute
Same institution · by research overlap
- Susan Matthews Rogers$6,104,430
- Timothy R Fennell$4,803,434
- Jon Eric Zibbell$3,906,039
- Scott F. Wetterhall$2,345,201
Others in their field
Top investigators on “Substance Use Disorder”
- Jeffrey H Samet · Boston University Medical Campus$89,407,012
- Randall J Bateman · Washington University$84,370,732
- David Heimbrook · Leidos Biomedical Research, Inc.$68,229,403
- Edward V Nunes · Columbia University Health Sciences$52,813,531
- Roger D. Weiss · Mc Lean Hospital (Belmont, Ma)$47,777,646
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
Substance Use DisorderServicesAlcohol Or Other Drugs UseMedicalDesignAdolescentResearch PersonnelAddictionHealthcareMeetingsMental HealthResponseMeasurementAreaCaringAdultBaseResourcesClinical ResearchDrug AbuseProviderClinicEvidence BasePatient Oriented
Grant awards (48)
Increasing access to opioid use disorder treatment by opening pharmacy-based medication units of opioid treatment programs$573,385
R01 · FY2024 · DA · contact PI
Increasing access to opioid use disorder treatment by opening pharmacy-based medication units of opioid treatment programs$718,340
R01 · FY2023 · DA · contact PI
Increasing access to opioid use disorder treatment by opening pharmacy-based medication units of opioid treatment programs$720,734
R01 · FY2022 · DA · contact PI
The impact of chronic pain on buprenorphine treatment retention among patients with opioid use disorder.$80,500
R03 · FY2021 · DA · contact PI
The impact of chronic pain on buprenorphine treatment retention among patients with opioid use disorder.$80,500
R03 · FY2020 · DA
Mid Southern Primary Care Networks Node$999,998
UG1 · FY2019 · DA · contact PI
Mid Southern Primary Care Networks Node$734,852
UG1 · FY2019 · DA · contact PI
Mid Southern Primary Care Networks Node$552,141
UG1 · FY2019 · DA · contact PI
Mid Southern Primary Care Networks Node$452,092
UG1 · FY2019 · DA · contact PI
Mid Southern Primary Care Networks Node$745,791
UG1 · FY2018 · DA · contact PI
Mid Southern Primary Care Networks Node$528,610
UG1 · FY2018 · DA · contact PI
Mid Southern Primary Care Networks Node$1,264,138
UG1 · FY2017 · DA · contact PI
Mid Southern Primary Care Networks Node$757,947
UG1 · FY2017 · DA · contact PI
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind$392,500
R01 · FY2017 · MD · contact PI
Mid Southern Primary Care Networks Node$121,928
UG1 · FY2017 · DA · contact PI
Mid Southern Primary Care Networks Node$814,688
UG1 · FY2016 · DA · contact PI
Mid Southern Primary Care Networks Node$775,477
UG1 · FY2016 · DA · contact PI
Project-003$678,482
UG1 · FY2016 · DA · contact PI
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind$260,064
R01 · FY2016 · MD · contact PI
Mid Southern Primary Care Networks Node$243,468
UG1 · FY2016 · DA · contact PI
Project-002$136,206
UG1 · FY2016 · DA · contact PI
Mid Southern Primary Care Networks Node$827,206
UG1 · FY2015 · DA · contact PI
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind$392,500
R01 · FY2015 · MD · contact PI
Mid Southern Primary Care Networks Node$157,092
UG1 · FY2015 · DA · contact PI
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind$392,500
R01 · FY2014 · MD · contact PI
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind$392,500
R01 · FY2013 · MD · contact PI
Classification of substance use disorders in adolescents$177,266
R01 · FY2013 · DA · contact PI
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies$355,053
R33 · FY2012 · DA · contact PI
Classification of substance use disorders in adolescents$184,652
R01 · FY2012 · DA · contact PI
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies$365,602
R33 · FY2011 · DA · contact PI
Classification of substance use disorders in adolescents$184,652
R01 · FY2011 · DA · contact PI
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies$377,303
R33 · FY2010 · DA · contact PI
Classification of substance use disorders in adolescents$189,150
R01 · FY2010 · DA · contact PI
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies$301,950
R21 · FY2009 · DA · contact PI
MDMA and Other Hallucinogen Use: Onset and Abuse/Dependence$145,236
R01 · FY2009 · DA · contact PI
Epdemiology of Non-Medical Prescription Anagesic Use$137,592
R01 · FY2009 · DA · contact PI
MDMA and Other Hallucinogen Use: Onset and Abuse/Dependence$145,236
R01 · FY2008 · DA · contact PI
Epdemiology of Non-Medical Prescription Anagesic Use$137,592
R01 · FY2008 · DA · contact PI
Epdemiology of Non-Medical Prescription Anagesic Use$140,400
R01 · FY2007 · DA · contact PI
MDMA and Other Hallucinogen Use: Onset and Abuse/Dependence$116,938
R01 · FY2007 · DA · contact PI
Inhalant Use/Dependence: Incidence and Comorbidity$43,733
R21 · FY2005 · DA
Inhalant Use/Dependence: Incidence and Comorbidity$180,107
R21 · FY2004 · DA
MATHEMATICAL MODELING TO HORMONAL CONTROL OF CARDIAC METABOLISM$25,090
P20 · FY2004 · RR
Inhalant Use/Dependence: Incidence and Comorbidity$180,406
R21 · FY2003 · DA
Treatment Utilization for Alcohol-Related Problems$170,624
R21 · FY2002 · AA
Treatment Utilization for Alcohol-Related Problems$168,957
R21 · FY2001 · AA
SUBSTANCE USE &DEPENDENCE PROBLEMS AMONG THE UNINSURED$89,048
R03 · FY2001 · DA
SUBSTANCE USE &DEPENDENCE PROBLEMS AMONG THE UNINSURED$89,145
R03 · FY2000 · DA